Spectrum Oncology Private Limited

Develops and sells pharmaceutical products, including drugs, intermediates, and cosmetics.

2008 | Mumbai, Maharashtra (India) | Under Liquidation
Last Updated:

Spectrum Oncology Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.19 M
  • Company Age 16 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 14.03%
  • Profit Growth 6.09%
  • Ebitda -15.23%
  • Net Worth -11.99%
  • Total Assets -3.31%

About Spectrum Oncology

Spectrum Oncology Private Limited (SOPL) is Under Liquidation company established on 01 May 2008 with its office registered at Mumbai, Maharashtra, India and has been running since 16 Year, 11 Months with a paid up capital of 0.19 M. According to MCA records, 3 Directors are linked to this company as of 03 Mar 2025.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U51397MH2008PTC181835

  • Company No.

    181835

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    01 May 2008

  • Date of AGM

    05 Jul 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma
Company report

Spectrum Oncology Private Limited

Explore comprehensive data for Spectrum Oncology Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Spectrum Oncology?

Board Members (3)

NameDesignationAppointment DateStatus
Purvish Parikh Country flag representing In Director 30-Jun-2009Current
Satyanarain Agarwala Country flag representing Us Director 01-May-2008Current
Arun Nanivadekar Country flag representing In Director 30-Jun-2009Current

Financial Performance of Spectrum Oncology.

Spectrum Oncology Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 14.03% increase. The company also saw a slight improvement in profitability, with a 6.09% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.99%.

Spectrum Oncology revenue growth over time
Spectrum Oncology profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
14.03%
Revenue from Operations
13.43%
Total Assets
-3.31%
Profit or Loss
6.09%
Net Worth
-11.99%
EBITDA
-15.23%

What is the Ownership and Shareholding Structure of Spectrum Oncology?

In 2023, Spectrum Oncology had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Spectrum Oncology?

Unlock and access historical data on people associated with Spectrum Oncology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Spectrum Oncology Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Spectrum Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Spectrum Oncology's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Spectrum Oncology

Recent activity within the organization

  • Annual General Meeting

    Spectrum Oncology Private Limited last Annual general meeting of members was held on 05 Jul 2023 as per latest MCA records.

  • Balance Sheet

    Spectrum Oncology Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Purvish Mahendra Parikh was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 15 years 9 months .

  • Director Appointment

    Arun Shankar Nanivadekar was appointed as a Director was appointed as a Director on 30 Jun 2009 & has been associated with this company since 15 years 9 months .

  • Director Appointment

    Satyanarain Rameshwardas Agarwala was appointed as a Director was appointed as a Director on 01 May 2008 & has been associated with this company since 16 years 11 months .

  • Company Incorporation

    Spectrum Oncology Private Limited was registered on 01 May 2008 with Roc Mumbai & aged 16 years 11 months as per MCA records.

Recent News, Updates & Announcement

Frequently asked questions

  • What is the Incorporation or founding date of Spectrum Oncology Private Limited?

    Spectrum Oncology Private Limited was incorporated on 01 May 2008.

  • What is authorized share capital and paid-up capital of Spectrum Oncology Private Limited?

    The authorized share capital of Spectrum Oncology Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.19 M.

  • Who are the current board members & directors of Spectrum Oncology Private Limited?

    Currently 3 directors are associated with Spectrum Oncology Private Limited.

    • Satyanarain Rameshwardas Agarwala
    • Purvish Mahendra Parikh
    • Arun Shankar Nanivadekar

  • What is the registered address of Spectrum Oncology Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Spectrum Oncology Private Limited is Ofc No 1 Sadhana Bldg Gr Flr 207 David Barreto Rd Opp Wadala Stn West India, Mumbai, Maharashtra, 400031.

  • What is the corporate identification number (CIN) and company number of Spectrum Oncology Private Limited?

    The corporate identification number (CIN) of Spectrum Oncology Private Limited is U51397MH2008PTC181835 and the company number is 181835 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Spectrum Oncology Private Limited?

    The Official website of Spectrum Oncology Private Limited is https://www.sppirx.com

  • What has been the recent revenue trend for Spectrum Oncology Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Spectrum Oncology Private Limited has risen by 14.03%.

  • What change has been observed in the net worth of Spectrum Oncology Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Spectrum Oncology Private Limited has experienced an downturn of -11.99%.

  • When was the last Balance Sheet of Spectrum Oncology Private Limited filed with the ROC?

    The most recent Balance Sheet for Spectrum Oncology Private Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Pharma Contract R&D